These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23764372)

  • 1. Muscle function and quality of life are not impaired in familial hypocalciuric hypercalcemia: a cross-sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene (CASR).
    Jakobsen NF; Rolighed L; Nissen PH; Mosekilde L; Rejnmark L
    Eur J Endocrinol; 2013 Sep; 169(3):349-57. PubMed ID: 23764372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardiovascular system in familial hypocalciuric hypercalcemia: a cross-sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene.
    Breum Jakobsen NF; Laugesen E; Rolighed L; Nissen PH; Poulsen PL; Pedersen EB; Mosekilde L; Rejnmark L
    Eur J Endocrinol; 2016 Oct; 175(4):299-309. PubMed ID: 27418061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
    Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
    Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
    Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A homozygous CaSR mutation causing a FHH phenotype completely masked by vitamin D deficiency presenting as rickets.
    Szczawinska D; Schnabel D; Letz S; Schöfl C
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E1146-53. PubMed ID: 24517148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia.
    Falchetti A; Gozzini A; Terranegra A; Soldati L; Vezzoli G; Leoncini G; Giusti F; Franceschelli F; Masi L; Tanini A; Cavalli L; Brandi ML
    Eur J Endocrinol; 2012 May; 166(5):933-40. PubMed ID: 22315359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.
    Vargas-Poussou R; Mansour-Hendili L; Baron S; Bertocchio JP; Travers C; Simian C; Treard C; Baudouin V; Beltran S; Broux F; Camard O; Cloarec S; Cormier C; Debussche X; Dubosclard E; Eid C; Haymann JP; Kiando SR; Kuhn JM; Lefort G; Linglart A; Lucas-Pouliquen B; Macher MA; Maruani G; Ouzounian S; Polak M; Requeda E; Robier D; Silve C; Souberbielle JC; Tack I; Vezzosi D; Jeunemaitre X; Houillier P
    J Clin Endocrinol Metab; 2016 May; 101(5):2185-95. PubMed ID: 26963950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study.
    Isaksen T; Nielsen CS; Christensen SE; Nissen PH; Heickendorff L; Mosekilde L
    Calcif Tissue Int; 2011 Oct; 89(4):285-94. PubMed ID: 21785908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status.
    Zajickova K; Vrbikova J; Canaff L; Pawelek PD; Goltzman D; Hendy GN
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2616-23. PubMed ID: 17473068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
    Watanabe S; Fukumoto S
    Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications.
    Eldeiry LS; Ruan DT; Brown EM; Gaglia JL; Garber JR
    Endocr Pract; 2012; 18(3):412-7. PubMed ID: 22232026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations.
    Hendy GN; Canaff L; Newfield RS; Tripto-Shkolnik L; Wong BY; Lee BS; Cole DE
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1311-5. PubMed ID: 24731014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism.
    Frank-Raue K; Leidig-Bruckner G; Haag C; Schulze E; Lorenz A; Schmitz-Winnenthal H; Raue F
    Clin Endocrinol (Oxf); 2011 Jul; 75(1):50-5. PubMed ID: 21521328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).
    Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM
    Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia.
    Szalat A; Shpitzen S; Tsur A; Zalmon Koren I; Shilo S; Tripto-Shkolnik L; Durst R; Leitersdorf E; Meiner V
    Endocrine; 2017 Mar; 55(3):741-747. PubMed ID: 28176280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial hypocalciuric hypercalcemia: a new mutation].
    Ubetagoyena Arrieta M; Castaño González L; Pérez de Nanclares Leal G; Arruebarrena Lizarraga D; Imaz Murguiondo M; Areses Trapote R
    An Pediatr (Barc); 2011 Jan; 74(1):47-50. PubMed ID: 21185797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiometabolic phenotyping of patients with familial hypocalcuric hypercalcemia.
    Wolf P; Krššák M; Winhofer Y; Anderwald CH; Zwettler E; Just Kukurová I; Gessl A; Trattnig S; Luger A; Baumgartner-Parzer S; Krebs M
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1721-6. PubMed ID: 24947037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium signaling regulates trafficking of familial hypocalciuric hypercalcemia (FHH) mutants of the calcium sensing receptor.
    Grant MP; Stepanchick A; Breitwieser GE
    Mol Endocrinol; 2012 Dec; 26(12):2081-91. PubMed ID: 23077345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation of the calcium-sensing receptor gene in a German subject with familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Papadakis M; Meurer N; Margariti T; Meyer A; Weyerbrock N; Dotzenrath C
    Hormones (Athens); 2016 Oct; 15(4):557-559. PubMed ID: 28222409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia.
    Pidasheva S; Canaff L; Simonds WF; Marx SJ; Hendy GN
    Hum Mol Genet; 2005 Jun; 14(12):1679-90. PubMed ID: 15879434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.